Intrathecal pumps are a special type of devices that are used for specific drug injection, particularly in the spinal cord. These pumps are widely used for chronic pain syndrome treatment and two types of intrathecal pumps including programmable pump and constant rate pump are usually used in several applications such as chronic pain and spasticity management. In addition, intrathecal pumps associated with advanced technology and most demandable among patients suffering from chronic pain.
Growing prevalence of cancer in various countries and increasing aging populations across the globe resulting in rising demand for intrathecal pumps globally. These are main reasons for high growth of the target product across the globe. In addition, an increasing number of patients suffering from chronic pain and rising advancement in intrathecal pumps are other reasons that support the high growth of the intrathecal pumps across the globe.
Increasing awareness among patients suffering from chronic pain about intrathecal pumps associated with advanced features and growing demands for programmable pump and constant rate pump across the globe. These are other factors helps to drive growth of the target product globally. In addition, increasing different types of chronic problems including cancer resulting in the growing demand for intrathecal pumps across the globe.
Furthermore, increasing neurodegeneration with brain iron accumulation disorders among patients and rising adoption of intrathecal pumps for long term treatments are other factors drive demand for intrathecal pumps in many regions. High availability of intrathecal pumps in the market and introduction of advanced healthcare products coupled with sophisticated features are important reasons that support for the significant growth of the target product, especially in emerging economies.
- By Type
- By Region
- By Application
Moreover, high focus of manufacturers on the development of technologically advanced products and rising introduction of advanced products across the globe are some factors that help to boost growth of the target market in the near future.
The spasticity management segment will account for the highest market share, owing to rising adoption of intrathecal pumps across the globe for spasticity treatment and management. In addition,
North America is one of the largest market followed by Europe intrathecal pumps market, owing to growing number of patient suffering from chronic pain and reimbursement policies in countries in these regions. In addition, increasing individual expenditure on healthcare services and the presence of key players in North America and Europe regions support for the growth of the intrathecal pumps market. Expanding healthcare sector, rising investment in healthcare infrastructure, and increasing geriatric populations especially in emerging economies such as India and China in Asia Pacific region will register substantial growth in the next 10 years. In addition, rising use of intrathecal pumps for metastatic cancer treatments and high demand for programmable pump in many countries in Asia Pacific region will support revenue growth of the market. Increasing NBIA (neurodegeneration with brain iron accumulation) disorders among patients in countries such as Israel, Brazil, Mexico, and South Africa in Latin America and Middle East & Africa regions.
Prominent players operating in the global intrathecal pumps market include Medtronic, Codman & Shurtleff (J&J), Flowonix, and Tricumed.